Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Lowering homocyst(e)ine levels can reverse skin and hair lightening by restoring enzyme activity needed for pigmentation.

Topical oligonucleotide therapy targets hair follicles effectively.

Pre-seeding scaffolds with fibroblasts improves skin wound healing.

New mutations in hair keratin genes can change hair structure and cause monilethrix, with nail issues more common in certain gene mutations.

K6/ODC transgenic mice are effective for quickly identifying cancer-causing chemicals.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Finasteride may treat baldness but less effective for those with 5α-reductase deficiency.

Monilethrix is linked to a gene cluster on chromosome 12.

Patients with alopecia areata have lower zinc levels, and zinc supplements might help.

Trichotillomania is a complex condition involving compulsive hair pulling that causes distress and hair loss.

High ornithine decarboxylase levels may lead to hair loss and cancer by increasing CK2 activity in the nucleus.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Sorafenib may cause hand-foot and stump syndrome, requiring early detection and management.

Beard and scalp hair cells have different gene expressions, which may affect beard growth characteristics.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Aggressive SLE treatment helped hair regrowth and improved oral plaque, but scalp lesions stayed.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

A common mutation in the hHb6 gene is linked to monilethrix, but other factors may also play a role.

WAA-QOL measures impact of hair loss on women's well-being.

Biotinidase deficiency can cause vision and walking problems in children and can improve with biotin treatment.

P-cadherin is crucial for hair follicle pigmentation but not skin pigmentation.

A new mouse mutation causes skin and hair issues, influenced by another gene.

Finasteride doesn't affect bone density in male rats.

ODC1 gene mutations cause a neurodevelopmental disorder with large head size, hair loss, and facial abnormalities.